Canexis Pharma AG is pleased to announce that it has received a high-profile delegation from Thailand. The visit marks a significant meeting between the young company…
Canexis Pharma AG has developed a modern hygiene concept. It is based on a detailed zone plan and extends over three floors for integrated process chains for the production of C…
Canexis Pharma AG is setting new standards with its completed interior construction. The planning of the building focused not only on a maximum solution, but also on a lean production infrastructure…
With the new electric steam generator from the JUMAG EDI series, Canexis Pharma AG achieves an output of 120 kW and at the same time has a space-saving and low-maintenance steam generator. That's how it goes…
The ECA event on GMP aspects for herbal medical products will take place on November 8th and 9th, 2022. Various experts will give presentations on topics relevant to the industry. …
We were proud to publish an article in the specialist magazine “Swiss Pharma”, issue 1/22. The topic of this issue was modern qualification with best practice examples. You will find and…
On July 29th we successfully put the double-stage short-path distillation into operation at the new Canexis Pharma AG site. The short-path distillation was specially designed according to the requirements…
On July 19th, the completed production building was successfully handed over from IE Life Science to Canexis Pharma AG. The first meeting took place in the first half of 2020, the...
Since May 15, 2021, an amendment to the Narcotics Act by the BAG has enabled pilot tests for the controlled distribution of cannabis for “pleasure purposes”. These are intended to provide a scientific...
Canexis Pharma AG is building its new company building southwest of Schlattingen as a two-story attic building with a total volume of 6500 cubic meters. The building is scheduled to be completed by fall 2022...
